WIGGINS MARK C 4
4 · Tracon Pharmaceuticals, Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
WIGGINS MARK C
Chief Business Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-01-28+80,000→ 80,000 totalExercise: $2.32Exp: 2032-01-27→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.